September 16, 2015.
Technology
Latest News
Advertisement
Advertisement
September 17, 2015.
September 17, 2015.
September 15, 2015.
September 14, 2015.
September 14, 2015.
September 14, 2015.
September 11, 2015.
September 10, 2015.
Pharmaceutical Executive
The age of genomics is giving rise to highly specialized diagnostic tools, targeted therapies, and personalized drug monitoring. This new generation of individualized treatments will require life sciences companies to evolve how they reach and educate the healthcare community. Are your commercial operations up to the task?
Pharmaceutical Executive
September 09, 2015.
Pharmaceutical Executive
September 09, 2015.
September 08, 2015.
September 03, 2015.
September 02, 2015.
The success of Apple's iWatch is part of the apparently unstoppable rise of wearable technology, in particular health and fitness applications, writes Peter Houston.
August 28, 2015.
Pharmaceutical Executive
GSK announces plan to divest its rights in ofatumumab for auto-immune indications for up to $1 billion.
Pharmaceutical Executive
August 27, 2015.
Pharmaceutical Executive
August 27, 2015.
August 26, 2015.
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5